CD21 Activators refer to a class of chemical compounds designed to modulate the activity of CD21, a cell surface protein also known as complement receptor 2 (CR2). CD21 is primarily found on the surface of B cells, follicular dendritic cells, and some epithelial cells. Its primary function is to bind to complement fragments and antigens, facilitating various immune responses. CD21 plays a crucial role in the immune system by assisting in the recognition and clearance of pathogens and immune complexes. CD21 Activators are specifically designed to interact with CD21 and modulate its signaling and binding properties.
These activators can influence the activation and function of B cells and other immune cells by enhancing or inhibiting the interaction between CD21 and its ligands. CD21 serves as a co-receptor for B-cell receptor (BCR) signaling and is involved in B cell activation, proliferation, and differentiation. Activators of CD21 enhance these processes by promoting CD21-mediated signaling events. On the other hand, CD21 is also responsible for capturing and presenting antigens to B cells, aiding in the generation of an immune response. CD21 Activators may also play a role in enhancing or inhibiting this antigen presentation function, depending on the specific compound and context. In summary, CD21 Activators are a class of chemical compounds designed to modulate the activity of CD21, a crucial cell surface protein in the immune system. Their ability to influence CD21-mediated processes can have significant implications for immune responses and the recognition and clearance of pathogens and antigens by immune cells.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
A JNK inhibitor, potentially affecting downstream CD21 mediated immune responses. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
Inhibits NF-kB, potentially altering CD21 related immune responses. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor, which could influence CD21 signaling pathways. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
A tyrosine kinase inhibitor, potentially involved in modulating CD21-mediated signaling. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits phosphoinositide 3-kinases, potentially affecting CD21 signaling. | ||||||